Actinium Pharma (ATNM) Announces Webinar Showcasing Actimab-A Post Phase 2 Trial Plans and Actimab-MDS Regulatory Update

October 22, 2018 8:09 AM

Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) announced today that it will host a conference call and webinar to provide ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found